For the quarter ending 2025-09-30, PGEN has $171,264K in assets. $129,396K in debts. $14,322K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 14,322 | 13,760 | ||
| Short-term investments | 106,813 | 45,993 | ||
| Trade, less allowance for credit losses of 0 as of both september30, 2025 and december31, 2024 | 580 | 327 | ||
| Other | 520 | 244 | ||
| Inventory | 3,059 | - | ||
| Prepaid expenses | 4,303 | 2,431 | ||
| Total current assets | 129,597 | 62,755 | ||
| Long-term investments | 2,508 | - | ||
| Property, plant and equipment, net | 14,813 | 14,695 | ||
| Intangible assets, net | 3,500 | 3,818 | ||
| Goodwill | 15,232 | 15,232 | ||
| Right-of-use assets | 4,861 | 4,806 | ||
| Other assets | 753 | 590 | ||
| Total assets | 171,264 | 101,896 | ||
| Accounts payable | 6,262 | 3,922 | ||
| Accrued compensation and benefits | 10,167 | 5,201 | ||
| Other accrued liabilities | 10,824 | 9,514 | ||
| Indemnification accruals | 3,213 | 3,213 | ||
| Deferred revenue | 480 | 413 | ||
| Current portion of lease liabilities | 1,123 | 930 | ||
| Total current liabilities | 32,069 | 23,193 | ||
| Outstanding principal balance | 100,000 | - | ||
| Unamortized debt discount and issuance costs | 7,110 | - | ||
| Long-term debt | 92,890 | - | ||
| Deferred revenue, net of current portion | 95 | 1,818 | ||
| Lease liabilities, net of current portion | 4,179 | 4,223 | ||
| Warrant liabilities | - | 78,558 | ||
| Other long-term liabilities | 163 | - | ||
| Total liabilities | 129,396 | 107,792 | ||
| Series a preferred stock, no par value, 81,000 shares authorized as of september30, 2025 and december31, 2024 zero and 79,000 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively (aggregate liquidation preference of zero as of september30, 2025 and 79,000 as of december31, 2024) | 0 | 30,883 | ||
| Common stock, no par value, 700,000,000 shares authorized as of september30, 2025 and 400,000,000 shares authorized as of december31, 2024 353,810,556 shares and 292,869,097 shares issued and outstanding as of september30, 2025 and december31, 2024, respectively | 0 | 0 | ||
| Additional paid-in capital | 2,359,689 | 2,134,711 | ||
| Accumulated deficit | -2,317,845 | -2,171,501 | ||
| Accumulated other comprehensive income | 24 | 11 | ||
| Total shareholders' equity | 41,868 | -36,779 | ||
| Total liabilities, mezzanine equity and shareholders' equity | 171,264 | 101,896 | ||
PRECIGEN, INC. (PGEN)
PRECIGEN, INC. (PGEN)